Heavy Atom Compound Choices
I've restricted this list to the commoner heavy atoms, adding exotics as
information becomes available. 1 Å is approx 12.3985 keV. CuKα
(1.5418 Å) is approx 8.041 keV.
A general description of the heavy atom screening process can be found in
Boggon and Shapiro (2000) Structure 8, R143-R149 and expansion on some
overlooked aspects of characterization can be found in
Garman and Murray (2003) Acta Cryst D59, 1903-1913
at
http://journals.iucr.org/d/issues/2003/11/00/ba5042/index.html. There's
also a good table for anomalous scatterers at CuKα and 1.08 Å
from Scripps.
Covalent Modifiers
These compounds - almost invariably transition metals - bind to His, Cys and Met groups within
the protein with semi-covalent interactions. Third row transition metals are usually
preferred because they are electron-dense but sometimes second row transition metals have
been used. Affinities of the bare ions for
the target groups (e.g. Hg2+ in HgCl2) can result in
partial protein denaturation as the ion burrows into the protein and
disrupts the fold. In consequence the affinities are often "turned down" by
using compounds that are already covalently linked to one or more groups.
With some transition metal ions, use of ligands with higher affinity than
water (bare ions assumed to be something like M(H2O)6 in solution),
like NH3, CN-, SCN- can also reduce
reactivity by being harder to displace than H2O. In the case of Platinum, the Pt-IV oxidation state is less
reactive than the Pt-II oxidation state. Mercury is often linked to bulky organic
groups (e.g. in PCMBS, PHMBS, EthylHgCl) which limits its ability to penetrate a protein molecule
and attach to internal Cys and disrupt the fold. Trimethyl Lead is a non-transition metal
that shows some covalent-type affinities and behaves quite differently from
the bare Pb2+ ion.
No corrections are made for
oxidation state in the f'' tables below and in general the values will
be shifted from these - I extracted these data from Ethan Merrit's site
at
http://skuld.bmsc.washington.edu/scatter/AS_periodic.html.
Compound |
Group |
Targets |
Edge |
f'' at 1.0 Å and CuKα |
HgCl2 |
Hg2+ |
Cys, His |
L-III, 12.284 keV, 1.009 Å, f'' 10, broad
| 10 and 7.7
|
AuCl3 |
Au3+ |
His, Cys |
L-III, 11.919 keV, 1.040 Å, f'' 10
| 9.1 and 6.9
| PtCl4 |
Pt2+ |
His, Met, Cys |
L-III, 11.564 keV, 1.072 Å, f'' 10
| 9.1 and 6.9
| PtCl6 |
Pt4+/Pt2+ |
His, Met, Cys |
L-III, 11.564 keV, 1.072 Å, f'' 10
| 9.1 and 6.9
| PbMethyl3 |
Pb2+ |
His, Cys |
L-III, 13.035 keV, 0.951 Å, f'' 10.1
| 4.3 and 8.5
|
Substitutions and Naturally Occurring Ions
Classically Seleno-methionine can substitute for S-Methionine with relatively
little purturbation of the structure and in some cases mutation of Leu to
Met can provide additional sites. Oxidation of SeMet is sometimes a
problem, usually kept in check with DTT or β-mercaptoethanol, but
alternatively one can force oxidation of SeMet - see
Sharff et al. (2000) Acta Cryst D56, 785-788
at
http://journals.iucr.org/d/issues/2000/06/00/li0349/index.html.
Because SeMet is not an epic anomalous scatterer you still need 1 per 40-50
amino acids (more, with weakly diffracting crystals) - although Boggon and Shapiro
suggest 1 per 100 is viable with care during data collection. However I have
successfully phased off the Zn2+ anomalous signal which is fairly comparable,
at a relatively impressive 1 Zn per 450 amino acids. Of course that Zn
was tightly bound and 100% occupied with a crystal that diffracted fairly
well. First row transition metals are moderately frequent in protein structures
and those in the range Fe-Zn have accessible L-III edges at most synchrotron
beamlines. They also have small anomalous signals at 1.0 Å. Mn is a bit
of a problem, however as its edge is at nearly 1.9 Å. Rarely,
Cacodylate can derivatize Cys residues to form Cys-S-AsO(Methyl)2 so
I have included the data for Arsenic as well - a few groups have used this as a phasing
method.
Compound |
Group |
Targets |
Edge |
f'' at 1.0 Å and CuKα |
SeMet |
Se |
(Met sites) |
K, 12.658 keV, 0.980 Å, f'' 3.8
| 1.1 and 0.5
|
Zinc |
Zn2+ |
(Metal sites His/Cys) |
K, 9.659 keV, 1.284 Å, f'' 3.9
| 2.6 and 0.7
|
Manganese |
Mn2+ |
(Metal sites Asp/Glu/His) |
K, 6.539 keV, 1.896 Å, f'' 4.0
| 2.7 and 1.4
| Arsenic |
As3+ |
(Cys via cacodylate) |
K, 11.867 keV, 1.045 Å, f'' 3.9
| 3.5 and 1.0
|
If your metalloprotein crystal diffracts really well you can phase the structure off metal ions with inaccessible edges simply by
exploiting the significant f'' signal at the high energy end of the absorption edge. For the structure of Cadmium-bound marine diatom
carbonic anhydrase (see Xu et al 2008) I used the
Cd f'' signal at 1.6 Å well above the L-I 3.1 Å absorption edge to successfully SAD phase the structure
with pretty good phases with about 4 electrons of anomalous scattering.
The fact that the crystal diffracted to better than 1.5 Å obviously helped here. Although not really
a heavy atom derivative there has been real progress with Sulfur-SAD structures (see for example
this article on Sulfur-SAD with Cr Kα radiation).
Non-covalent Modifiers
Under some circumstances the cyanide derivatives of Hg, Pt, Au act essentially
as anions and fall into this class. Cyanide is often extremely difficult to displace
from a transition metal ion. However we will assume that the table
below is mainly plain cations that bind to proteins via electrostatic (and
possibly h-bond) interactions. Over the years this has tended to be
UO22+, Pb2+ and the Lanthanides. The Lanthanides are
getting closer scrutiny because they have rather considerable f'' values at
their L-III edges and still pretty substantial f'' values at 1.0 Å. A
few of them are pretty good at CuKα too.
Zbigniew Dauter et al. has pioneered the use of Bromide (Br-) and
Iodide (I-) for potential quick-and-dirty derivitization for SAD/MAD
data collection at synchrotron beamlines (Br) or MIR/SIRAS at home sources (I). In my
hands this hasn't really paid off and you need existing phases of at least
mediocre quality to even find the Br or I atoms but there are at least some
structures which have been phased this way.
Lanthanide complexes have been getting rather more attention lately.
Lanthanides replace Calcium in certain circumstances - I think William Weiss's
Holmium derivative of Mannose Binding Protein might be the first example of
that in a MAD context, back in the early 1990's, but recent papers suggest
compounds like Gd-HPDO3A might be more general heavy atom derivatives with
strong anomalous scattering properties. The basic problem with some of the
Lanthanides is that their L-III edge is up beyond CuKα, often too low energy
to be accessible for many synchrotron beamlines, but Ytterbium
is better in this regard. See Girard et al (2002) Acta Cryst D58, 1-9
at
http://journals.iucr.org/d/issues/2002/01/00/li0415/index.html. Some of the
Lanthanides have a pretty good anomalous signal at CuKα if your crystal
diffracts reasonably well (i.e. Sm).
Xenon and Krypton have also been used as derivatives despite the fact that they
are monatomic noble gasses and therefore do not undergo any chemical reactions -
you can force them in your crystal in some cases by the use of pressurization.
Xe is the heavier of the two, with good f'' at CuKΑ,
but Kr has an accessible MAD edge. They tend to bind in the hydrophobic core of proteins.
Uranium compounds, if you can still buy it without attracting the attention of the FBI, are still
good heavy atoms, with good f'' values at CuKα and 1.0 Å.
U6+ is so polarising it strips the protons off waters and the relevant ion is the UO22+
group. It also has an epic MIR phasing signal, if you can find an isomorphous native.
Compound |
Group |
Targets |
Edge |
f'' at 1.0 Å and CuKα |
UO2(NO3)2 |
UO22+ |
Glu/Asp etc |
inaccessible
| 6.9 and 13.4
|
Pb(OAc)2 |
Pb2+ |
Glu/Asp etc |
L-III, 13.035 keV, 0.951 Å, f'' 10.1
| 4.3 and 8.5
| Sm(OAc)3 |
Sm3+ |
Glu/Asp, Ca sites |
L-III, 6.716 keV, 1.846 Å, f'' 10.6
| 6.1 and 12.1
| Ho(OAc)3 |
Ho3+ |
Glu/Asp, Ca sites |
L-III, 8.071 keV, 1.536 Å, f'' 10.6
| 8.2 and 3.7
| Yb(OAc)3 |
Yb3+ |
Glu/Asp, Ca sites |
L-III, 8.944 keV, 1.386 Å, f'' 10.5
| 9.7 and 4.4
| NaBr |
Br- |
Arg,Lys etc |
K, 13.474 keV, 0.920 Å, f'' 3.8
| 0.6 and 1.3
| NaI |
I- |
Arg,Lys etc |
inaccessible
| 3.3 and 6.8
| Kr |
Kr |
none |
K, 14.326 keV, 0.866 Å, 3.8
| 0.7 and 1.4
| Xe |
Xe |
none |
inaccessible
| 3.6 and 7.3
|
Clusters
Clusters have the advantage that they magnify the scattering due to a single heavy atom binding to a site. Ta6Br12
has been fairly widely used as a derivative. The tremendous advantage is the enormous f'' signal at low resolution, however this signal
drops precipitously to near zero around 6Å and is rather more modest at higher resolutions. The cluster is also often rotationally
disordered with the crystal since it binds with less-specific electrostatic interactions. Nevertheless it was quite invaluable as part of the
structure solution of the PP2A ABC holoenzyme structure, where we lacked a good model for the B subunit and the low resolution
Ta6Br12 phases were enough to place the WD40 domain with enough precision to start building.
(See:
A selection of reference on the Ta6Br12 cluster are:
-
"Ta6Br(2+)12, a tool for phase determination of large biological assemblies by X-ray crystallography."
Knäblein J, Neuefeind T, Schneider F, Bergner A, Messerschmidt A, Löwe J, Steipe B, Huber R. (1997) J Mol Biol. 270:1-7.
-
"The suitability of Ta6Br12(2+) for phasing in protein crystallography."
Neuefeind T, Bergner A, Schneider F, Messerschmidt A, Knablein (1997)
J. Biol Chem. 378:219-21.
-
"Phasing at high resolution using Ta6Br12 cluster."
Banumathi S, Dauter M, Dauter Z. (2003) Acta Crystallogr D Biol Crystallogr. 59:492-8.
-
"MAD phasing using the (Ta6Br12)2+ cluster: a retrospective study."
Pasternak O, Bujacz A, Biesiadka J, Bujacz G, Sikorski M, Jaskolski M. (2008)
Acta Crystallogr D Biol Crystallogr. 64:595-606.
Others, particularly people working with the huge ribosome structures, have exploited other heavy atom clusters. For example see:
Thygesen J, Weinstein S, Franceschi F, Yonath A.
"The suitability of multi-metal clusters for phasing in crystallography of large macromolecular assemblies." (1996)
Structure 4: 513-8.
Most recently some novel compounds have been introduced, including the I3C "magic triangle" developed by Tobias Beck:
"A magic triangle for experimental phasing of macromolecules." Beck, T., Krasauskas, A., Gruene, T. & Sheldrick, G.M.(2008)
Acta Crystallogr. Section D 2008, 64:1179-1182. Link to PDF of article
via Tobias's site.
Heavy Atom Derivatives used for Membrane Protein Structures
See "Membrane's Eleven: heavy-atom derivatives of membrane-protein crystals."
J. P. Morth, T. L. Sørensen and P. Nissen (2006) Acta Cryst D62, 877-862.
"Rational" Prediction of Heavy Atom Binding
Published as Sugahara et al (2005) Acta Cryst D61, 1302-1305 and
available online. The associated website is:
http://www.rsgi.riken.go.jp/.
Alternatively you can do your own leg-work at browse the
Heavy Atom Databank at
http://www.sbg.bio.ic.ac.uk/had/heavyatom.html.
Assorted References Related to this Subject
- Garman E, Murray JW. Heavy-atom derivatization. Acta Crystallogr D. 2003, 59:1903-1913.
- Sun PD, Radaev S. Generating isomorphous heavy-atom derivatives by a quick-soak method. Part II: phasing of new structures. Acta Crystallogr D. 2002, 58:1099-1103.
- Panjikar S, Tucker PA. Phasing possibilities using different wavelengths with a xenon derivative. J. Appl. Cryst. 2002, 35, 261-266.
- Cohen A, Ellis P, Kresge N, Soltis SM. MAD phasing with krypton. Acta Crystallogr D. 2001, 57:233-238.
- Garman E. Leaving no element of doubt: analysis of proteins using microPIXE. Structure Fold Des. 1999, 7:R291-299.
- Soltis SM, Stowell MHB, Wiener MC, Phillips GN, Rees DC. Successful flash-cooling of xenon-derivatized myoglobin crystals J. Appl. Cryst. 1997, 30:190-194.
- Gonzalez A. Optimizing data collection for structure determination. Acta Crystallogr D. 2003, 59:1935-1942.
- Leslie AG, Powell HR, Winter G, Svensson O, Spruce D, McSweeney S, Love D, Kinder S, Duke E, Nave C. Automation of the collection and processing of X-ray diffraction data - a generic approach. Acta Crystallogr D. 2002, 58:1924-1928.
- Gonzalez A, Pedelacq J, Sola M, Gomis-Ruth FX, Coll M, Samama J, Benini S. Two-wavelength MAD phasing: in search of the optimal choice of wavelengths. Acta Crystallogr D. 1999, 55:1449-1458.
- Teplyakov A, Oliva G, Polikarpov I. On the choice of an optimal wavelength in macromolecular crystallography. Acta Crystallogr D. 1998, 54:610-614.
- Garman EF. Modern methods for rapid x-ray diffraction data collection from crystals of macromolecules. Methods Mol Biol. 1996, 56:87-126.
- Helliwell JR. Overview and new developments in softer X-ray (2A < lambda < 5A) protein crystallography. J Synchrotron Radiat. 2004, 11:1-3.
- Giacovazzo C, Siliqi D. Phasing via SAD/MAD data: the method of the joint probability distribution functions. Acta Crystallogr D. 2004, 6:73-82.
- Dall'Antonia F, Baker PJ, Schneider TR. Optimization of selenium substructures as obtained from SHELXD. Acta Crystallogr D. 2003, 59:1987-1994.
- Dodson E. Is it jolly SAD? Acta Crystallogr D. 2003, 59:1958-1965.
- Retailleau P, Prange T. Phasing power at the K absorption edge of organic arsenic. Acta Crystallogr D. 2003, 59:887-896.
- Uson I, Schmidt B, von Bulow R, Grimme S, von Figura K, Dauter M, Rajashankar KR, Dauter Z, Sheldrick GM. Locating the anomalous scatterer substructures in halide and sulfur phasing. Acta Crystallogr D. 2003, 59:57-66.
- Weeks CM, Adams PD, Berendzen J, Brunger AT, Dodson EJ, Grosse-Kunstleve RW, Schneider TR, Sheldrick GM, Terwilliger TC, Turkenburg MG, Uson I. Automatic solution of heavy-atom substructures. Methods Enzymol. 2003, 374:37-83.
- Yang C, Pflugrath JW, Courville DA, Stence CN, Ferrara JD. Away from the edge: SAD phasing from the sulfur anomalous signal measured in-house with chromium radiation. Acta Crystallogr D. 2003, 59:1943-1957.
- Dauter Z. New approaches to high-throughput phasing. Curr Opin Struct Biol. 2002, 12:674-678.
- Dauter Z. One-and-a-half wavelength approach. Acta Crystallogr D. 2002, 58:1958-1967.
- Dauter Z, Dauter M, Dodson E. Jolly SAD. Acta Crystallogr D. 2002, 58:494-506.
- Yang C, Pflugrath JW. Applications of anomalous scattering from S atoms for improved phasing of protein diffraction data collected at Cu Kalpha wavelength. Acta Crystallogr D. 2001, 57:1480-1490.
- Yu-dong L, Harvey I, Yuan-xin G, Chao-de Z, Yi-zong H, Hai-fu F, Hasnain SS, Hao Q. Is single-wavelength anomalous scattering sufficient for solving phases? A comparison of different methods for a 2.1 A structure solution. Acta Crystallogr D. 1999, 55:1620-1622.